Shima Daisuke | Cardiovascular and Metabolism Therapeutics, Pfizer Japan Inc
スポンサーリンク
概要
関連著者
-
Ogawa Hisao
Department Cardiovascular Medicine Kumamoto University:division Of Intensive Care Unit Kumamoto Univ
-
Matsuzaki Masunori
Division Of Cardiology Department Of Medicine And Clinical Science Graduate School Of Medicine Yamag
-
Goto Shinya
Department Of Cardiology Tokai University
-
Shima Daisuke
Cardiovascular and Metabolism Therapeutics, Pfizer Japan Inc
-
Ogawa Hisao
Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University
-
Hiro Shintaro
Clinical Statistics, Pfizer Japan Inc
-
HIRO Shintaro
Clinical Statistics Pfizer Japan Inc
著作論文
- Randomized, Double-Blind Trial to Evaluate the Safety of Apixaban With Antiplatelet Therapy After Acute Coronary Syndrome in Japanese Patients (APPRAISE-J)
- Randomized, Double-Blind Trial to Evaluate the Safety of Apixaban With Antiplatelet Therapy After Acute Coronary Syndrome in Japanese Patients (APPRAISE-J)